Table I. Inhibition of BPDE-induced NFκB and AP-1 activity by fractions of the ethanol and water extracts of freeze-dried black raspberriesa,b.
Ethanol fractions | Water fractions | ||||||||
---|---|---|---|---|---|---|---|---|---|
HPLC fraction no. | NFκB activity | AP-1 activity | HPLC fraction no. | NFκB activity | AP-1 Activity | ||||
Concentration of fraction in 0.1% DMSO (μg/ml) | Concentration of fraction in 0.1% DMSO (μg/ml) | ||||||||
50 | 10 | 50 | 10 | 50 | 10 | 50 | 10 | ||
% Inhibition relative to BPDE (2 μM) and no added fraction | % Inhibition relative to BPDE (2 μM) and no added fraction | ||||||||
1a | −19.1 | −1.2 | NTc | NT | 1a and 1b | 14.5 | 9.3 | −4.0 | 1.0 |
1b | 2.9 | 8.3 | NT | NT | |||||
1c | 17.6 | 6.0 | 5.0 | 3.6 | 1c | 32.7 | 11.2 | 30.0 | −20.0 |
1d | −44.1 | 40.5 | 24.8 | −19.3 | 1d | 53.6 | 45.8 | 0.0 | −4.0 |
1e | 26.5 | 46.4 | 0.0 | −9.6 | 1e | 75.5 | 65.4 | 56.0 | 6.0 |
1f and 1g | 67.6 | 31.0 | 25.7 | −3.6 | 1f and 1g | 81.8 | 50.5 | 76.0 | 42.0 |
2a | 63.2 | 81.0 | 25.7 | 9.6 | 2 | 73.6 | 55.1 | 48.0 | 6.0 |
2b | 45.6 | 77.4 | 26.7 | −26.5 | |||||
3a | 52.9 | 36.9 | 18.8 | −2.4 | 3a | 65.5 | 44.9 | 48.0 | 25.0 |
3b | 45.6 | −15.5 | 32.7 | −20.5 | 3b and 3c | 72.7 | 67.3 | 89.0 | 50.0 |
3c | 70.6 | 64.3 | 57.4 | 0.0 | |||||
4a | 42.6 | 60.7 | 5.9 | −30.1 | 4a | 81.8 | 51.4 | 68.0 | 35.0 |
4b | 95.6 | 60.7 | 77.2 | 26.5 | 4b | 80.0 | 29.9 | 76.0 | 45.0 |
4c | 75.5 | 48.6 | 79.0 | 41.0 | |||||
5 | 100.0 | 83.3 | 96.0 | 51.8 | 5 | 93.6 | 57.9 | 92.0 | 63.0 |
6 | 100.0 | 52.4 | 91.1 | 53.0 | 6 | 99.1 | 50.5 | 93.0 | 72.0 |
7a | 94.7 | 63.3 | 97.0 | 68.7 | 7a | 83.6 | 22.4 | 94.0 | 61.0 |
7b | 57.9 | 43.3 | 34.7 | 1.2 | 7b | 87.3 | 57.9 | 82.0 | 51.0 |
7c | 30.3 | 17.8 | 11.8 | −13.3 | 7c | 97.3 | 72.0 | 88.5 | 55.1 |
8a | 100.0 | 76.7 | 91.4 | 65.1 | 8a | 97.3 | 70.7 | 82.7 | 24.5 |
8b | 67.1 | 34.4 | 24.7 | −19.3 | 8b | 98.2 | 66.7 | 73.1 | 10.2 |
8c | 27.6 | 51.1 | 26.9 | 6.0 | 8c | 64.5 | 28.0 | −48.1 | −63.3 |
9a | 26.3 | 34.4 | 41.9 | −6.0 | 9 | 91.8 | 78.7 | 57.7 | −10.2 |
10a | 50.0 | 17.8 | 50.5 | 9.6 | 10a | 63.6 | 25.3 | −117 | −143 |
10b | 86.8 | 65.6 | 77.4 | 44.6 | 10b | 40.0 | 33.3 | −140 | −131 |
10c | 100.0 | 72.2 | 81.7 | 73.5 | 10c | 70.0 | 30.7 | −50.0 | −85.7 |
10d | 14.5 | 16.7 | −6.5 | −34.9 | 10d | 61.8 | −5.3 | −137 | −139 |
10e | −5.3 | 41.1 | 8.6 | −2.4 | 10e | 56.4 | −6.7 | −129 | −116 |
10f | 5.3 | 12.2 | 65.6 | 30.1 | 10f | 51.8 | −34.7 | −148 | −155 |
10g | 15.8 | 34.4 | −21.5 | −31.3 |
See Materials and methods for details of NFκB and AP-1 assays.
Highlighted fractions had >50% inhibitory activity for at least one concentration in both assays.
NT, not tested.